The Duration of Clinical Remission of Photochemotherapy and Narrow-Band UV-B Phototherapy in the Treatment of Psoriasis: A Retrospective Study

PUVA and UVB-NB phototherapy have an established role in the treatment of moderate-to-severe psoriasis. Even though psoriasis patients often require continuous treatments, inadequate attention is devoted to the duration of remission after the treatment. The purpose of this retrospective study is to assess which phototherapeutic regimen induces a longer remission. Twenty patients with psoriasis were included:10 patients received PUVA and 10 patients received UVB-NB. We consider as a “cycle” the therapeutic period needed to reach clinical remission. The comparison between the average number of days in remission revealed that PUVA induces a longer remission period than UVB-NB: PUVA 386 days (ds ±321), UVB-NB 298 days (ds ± 257). Although the difference of the duration of remission is not statistically significant, a trend is seen and patients treated with PUVA remain clear for a period about 88 days longer than that of patients treated with UVB-NB. The differences in the duration of remission of psoriasis therapies must be considered in planning a patient's course of treatment.

[1]  M. Lebwohl.  A clinician's paradigm in the treatment of psoriasis. , 2005, Journal of the American Academy of Dermatology.

[2]  J. Koo,et al.  Quality-of-life issues in psoriasis. , 2004, Dermatologic clinics.

[3]  J. Koo,et al.  Narrow‐band ultraviolet B radiation: a review of the current literature , 2004, International journal of dermatology.

[4]  M. Zanolli.  Phototherapy treatment of psoriasis today. , 2003, Journal of the American Academy of Dermatology.

[5]  S. Rogers,et al.  Narrowband UV-B (TL-01) phototherapy vs oral 8-methoxypsoralen psoralen-UV-A for the treatment of chronic plaque psoriasis. , 2003, Archives of dermatology.

[6]  M. Lebwohl,et al.  Treatment of psoriasis. Part 2. Systemic therapies. , 2001, Journal of the American Academy of Dermatology.

[7]  M. Landthaler,et al.  Phototherapy of Psoriasis: Comparative Experience of Different Phototherapeutic Approaches , 2001, Dermatology.

[8]  B. Diffey,et al.  A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis. , 1999, Journal of the American Academy of Dermatology.

[9]  M. Lebwohl,et al.  Duration of remission of psoriasis therapies. , 1999, Journal of the American Academy of Dermatology.

[10]  A Tanew,et al.  Narrowband UV-B phototherapy vs photochemotherapy in the treatment of chronic plaque-type psoriasis: a paired comparison study. , 1999, Archives of dermatology.

[11]  M. Dahl.  The carcinogenic risk of treatments for severe psoriasis , 1995 .

[12]  H. Wulf,et al.  Differences in narrow-band ultraviolet B and broad-spectrum ultraviolet photocarcinogenesis in lightly pigmented hairless mice. , 1994, Photodermatology, photoimmunology & photomedicine.

[13]  J. C. Leun,et al.  A new development in UVB phototherapy of psoriasis , 1988, The British journal of dermatology.

[14]  J. Parrish,et al.  Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. , 1974, The New England journal of medicine.

[15]  A. Blum,et al.  No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study. , 2004, Acta dermato-venereologica.

[16]  J. C. van der Leun,et al.  Comparison of narrow-band UV-B phototherapy and PUVA photochemotherapy in the treatment of psoriasis. , 1990, Acta dermato-venereologica.